SCHEMBL7137206

SCHEMBL7137206

CCOC(=O)c1ccc(C(=O)OCC)c(-c2ccc(-c3ccc(OCCC(C)CCCC(C)C)cc3)cc2)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RARB P10826 1/20 0.48
KCNH2 Q12809 1/20 0.44
HRH3 Q9Y5N1 1/20 0.44
MAPK1 P28482 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
LMNA P02545 2/20 0.41
HSD17B10 Q99714 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
DHFR P00374 1/20 0.40
TP53 P04637 2/20 0.40
FDPS P14324 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALOX5 P09917 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 1/20 0.38
TBXAS1 P24557 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5885726 0.90 RARB (0.45) RARBKCNH2HRH3MAPK1TDP1
SCHEMBL27491939 0.87 RARB (0.48) RARBMAPK1L3MBTL1LMNAHSD17B10
SCHEMBL6857231 0.84 FFAR1 (0.41) RARBMAPK1TDP1LMNAHSD17B10
SCHEMBL2864794 0.84 RARB (0.45) RARBKCNH2HRH3MAPK1TDP1
SCHEMBL6858932 0.83 GAA (0.42) RARBMAPK1TDP1L3MBTL1LMNA
SCHEMBL7139175 0.81 PTPN11 (0.56) RARBKCNH2HRH3TDP1L3MBTL1
SCHEMBL21157703 0.80 RARB (0.64) RARBKCNH2HRH3MAPK1TDP1
SCHEMBL5885728 0.78 L3MBTL1 (0.46) MAPK1TDP1L3MBTL1FDPSALOX5
SCHEMBL10739843 0.77 RARB (0.57) RARBNPC1RAB9ATP53TSHR
SCHEMBL6858906 0.76 NR1H4 (0.39) RARBMAPK1LMNARAB9AFDPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6509507-B2 Reacting a 6-membered aromatic ring with 1,4- position ester or benzylic OH groups with a second aromatic in a palladium catalyzed cross-coupling; electroluminescence AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 2003-01-21 US disclosed
US-6458909-B1 SOLID-STATE LIGHT SOURCES FOR A SERIES OF APPLICATIONS, PREDOMINANTLY IN THE FIELD OF DISPLAY ELEMENTS HOECHST AKTIENGESELLSCHAFT (DE) 2002-10-01 US disclosed
US-20020087030-A1 Polymerizable biaryls, process for their preparation and their use MERCK PATENT GMBH (DE) 2002-07-04 US disclosed
US-6323373-B1 USED TO OBTAIN POLYMERS WHICH ARE USED AS ELECTROLUMINESCENCE MATERIALS AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) 2001-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020087030-A1 Polymerizable biaryls, process for their preparation and their use PAH, TYR, PAICS RARB 1893/4885KCNH2 1223/4885HRH3 145/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.